ALK | Allergy solutions for life
ALK

Pioneering in the field of respiratory allergies for more than a century, we've embarked on a mission to help more people, with more solutions, more efficiently.

News

  • Post date
    12/20/2024
    ALK – Financial calendar for the 2025 financial year
  • Post date
    12/18/2024
    Positive results advance peanut tablet to phase II development
  • Post date
    12/12/2024
    ACARIZAX® approved in Europe for treatment of young children
  • Post date
    11/27/2024
    ALK’s pivotal phase 3 trial in children published in reputable scientific journal
  • Post date
    11/14/2024
    Nine-month interim report (Q3) 2024 (unaudited)
  • Post date
    11/09/2024
    ALK licenses rights to neffy®, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)
  • Post date
    11/07/2024
    Invitation to the presentation of ALK’s results for the first nine months (Q3) 2024 on Thursday 14 November 2024
  • Post date
    08/27/2024
    Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
  • Post date
    08/22/2024
    ALK upgrades its full-year revenue and earnings outlook
ALK corporate strategy 2024-2028
As the pioneers of allergy solutions, we are stepping into the next 100 years with a mission to help more people, with more solutions, more efficiently. We call it Allergy+.
100 years of pioneering allergy solutions
A new book has been written about ALK’s fascinating development in the field of allergy
The hunt for a vaccine – a podcast in five episodes
A fascinating story about ALK and the company’s 100 years of hunting allergy vaccines have been turned into a captivating podcast.
ALK in brief

Avatar

Allergy solutions

Allergy is caused by an overreaction of the body’s immune system to substances that in most cases would otherwise be harmless. Learn about the chronic disease, diagnosis, and treatment options.

Avatar

Sustainability

We aim to operate in a sustainable and ethical manner across our business and we underpin these aims with a range of policies and commitments.

Avatar

Careers

Become part of a team that is passionate about making a difference for people living with allergy. In our global company, we share expertise and knowledge across boarders and cultures and have a focus on continuous employee development.

Image
Front Page Video Thumbnail
Pioneers in helping people with allergies

For 100 years, ALK has consistently devised and developed major advances for the treatment of allergy